Dementia Consortium Funds Research to Treat Alzheimer’s

Dementia Consortium Funds Research to Treat Alzheimer’s
UK-based Dementia Consortium announced that it will grant £500,000 ($790,000) in funding to a collaborative research effort that includes academics from the University of Southampton and drug discovery specialists from the medical research charity MRC Technology. The newly-funded project will focus on targeting the immune system in order to develop new therapeutic options to treat Alzheimer's disease. A team led by Dr. Diego Gomez-Nicola will base its research on the recent finding that the protein CSF1R found in the immune system may be crucial for the development of effective treatments for Alzheimer's. In collaboration with MRC Technology specialists, the researchers will seek to study the brain's response to nerve cell death and develop novel therapies, focusing on the inflammatory response of the brain that is disturbed by the disease, provoking further neurological damage. Dr. Gomez-Nicola, who serves as Career Track Lecturer and MRC NIRG fellow at the University of Southampton, explained in a press release that, "inflammation is the body's response to damage and something we've all experienced but sometimes these mechanisms to defend the body go awry. In Alzheimer's disease, specialised immune cells called microglia are a little too eager to clear damage. Their ranks swell and activity increases, with
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *